Product Information

TOPIRAMATE 100 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0593 per EA under NDC 47335071186. Its NADAC has been published 588 times since Aug 12, 2015.

FDA first approved this application on Mar 27, 2009.

TOPIRAMATE 100 MG TABLET

Topiramate
$0.0593per EA

Strength

100 mg/1

NDC

47335071186

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA090278

FDA Approved

3/27/2009

On Market Since

12/15/2014

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE 100 MG TABLET has been published 588 times since Aug 12, 2015, and over the history we have for it it has declined 36.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0593 per EA
All-time high$0.0937 (Aug 12, 2015)
All-time low$0.0486 (Nov 20, 2024)
52-week high$0.0620
52-week low$0.0550
Median price$0.0667
Average price$0.0683
Largest weekly change+33.1% (Aug 21, 2024)
Weeks tracked588
Tracking sinceAug 12, 2015

Price History

1W

0.0%

1M

+4.6%

3M

+7.8%

6M

-0.3%

1Y

-4.2%

3Y

-5.7%

5Y

-7.6%

All

-36.7%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOPIRAMATE 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE 100 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.0593 per EA (NDC 47335071186), effective Nov 11, 2026.

How has the price of TOPIRAMATE 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE 100 MG TABLET has declined 36.7%. It has been tracked across 588 weekly CMS publications since Aug 12, 2015.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE 100 MG TABLET?

Since Aug 12, 2015, the NADAC for TOPIRAMATE 100 MG TABLET has ranged from a low of $0.0486 (Nov 20, 2024) to a high of $0.0937 (Aug 12, 2015), with a median of $0.0667 per EA.

Are there cheaper alternatives to TOPIRAMATE 100 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TOPIRAMATE 100 MG TABLET, is $0.0550 per EA — about 7% below TOPIRAMATE 100 MG TABLET.

Who manufactures TOPIRAMATE 100 MG TABLET?

TOPIRAMATE 100 MG TABLET (NDC 47335071186) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.